Explore ARDC

RAiD https://raid.org/10.82287/a8834a73
Pipeline Accelerator - Voucher Scheme - 24-25 Round 1

Dates

Start Date
01-Sep-2024
End Date
30-Dec-2024

Titles

Title
Pipeline Accelerator - Voucher Scheme - 24-25 Round 1
Title Type
Primary
Title Type:
Primary
 Preferred full description or abstract.
Start Date
01-Sep-2024
End Date
30-Dec-2024
Language

Descriptions

No Entries

Contributors

Leader
Yes
Contact
Yes
Positions
Position
Principal or Chief Investigator
Position:
Principal or Chief Investigator
 Principal investigator refers to the person(s) in charge of a research project
Start Date
01-Sep-2024
End Date
---
Roles
No Entries

Organisations

Name
Phenomics Australia

Roles
Role
Lead Research Organisation
Role:
Lead Research Organisation
 The research organistion administratively responsible for the project; administering organisation
Start Date
2026-03-12
End Date
---

RelatedObjects

Citation

Phenomics Australia. (2024). Developing a humanized mouse model for Multiple Sclerosis. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2024). Studying enhancer function and the genetics of blood cell development from human induced pluripotent stem cells. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2024). Screening for new treatments for glomerular disease with a new stem cell reporter line. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2024). Testing precision medicines for Alzheimer's disease using advanced 3D human brain models. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2024). Creating an immunocompetent preclinical prostate cancer model to investigate targeting a tumour-driving transcription factor to stop disease. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2024). Developing rapid Pharmacodynamic AURKA Targeted Protein Degrader screening mice. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2024). Developing novel models of cardiomyopathy for therapeutic testing. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2024). Gene therapy to cure primary immunodeficiencies. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2024). Overcoming Silence in Neurodevelopmental Disorder Gene Diagnosis. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2024). Engineering genetic mouse models of severe childhood epilepsy to test the efficacy of venom peptides as a therapeutic strategy. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2024). Identifying patient-specific treatments that target plasticity in colorectal cancer via high throughput screening. Phenomics Australia.
Type
Funding
Categories
Output

Alternate Identifier

No Entries

Alternate URLs

No Entries

Related RAiDs

No Entries

Access

Type
Open Access
Type:
Open Access
 Open access refers to a resource that is immediately and permanently online, and free for all on the Web, without financial and technical barriers.The resource is either stored in the repository or referenced to an external journal or trustworthy archive.
Language
Text
Embargo Expiry

Subjects

No Entries

Raw Data

{
  "access": {
    "type": {
      "id": "https://vocabularies.coar-repositories.org/access_rights/c_abf2/",
      "schemaUri": "https://vocabularies.coar-repositories.org/access_rights/"
    }
  },
  "alternateIdentifier": [],
  "alternateUrl": [],
  "contributor": [
    {
      "contact": true,
      "id": "https://orcid.org/0000-0002-5324-8398",
      "leader": true,
      "position": [
        {
          "id": "https://vocabulary.raid.org/contributor.position.schema/307",
          "schemaUri": "https://vocabulary.raid.org/contributor.position.schema/305",
          "startDate": "2024-09-01"
        }
      ],
      "role": [],
      "schemaUri": "https://orcid.org/",
      "status": "AUTHENTICATED",
      "orcidInfo": {
        "orcidId": "0000-0002-5324-8398",
        "displayName": "Michael Dobbie",
        "nameType": "constructed",
        "visibility": "public",
        "authenticated": true,
        "claimed": true,
        "verified": false,
        "profileUrl": "https://orcid.org/0000-0002-5324-8398",
        "style": "underline"
      }
    }
  ],
  "date": {
    "endDate": "2024-12-30",
    "startDate": "2024-09-01"
  },
  "description": [],
  "identifier": {
    "id": "https://raid.org/10.82287/a8834a73",
    "license": "Creative Commons CC-0",
    "owner": {
      "id": "https://ror.org/0201hm243",
      "schemaUri": "https://ror.org/",
      "servicePoint": 20000016,
      "servicePointName": "PhenomicsAus"
    },
    "raidAgencyUrl": "https://static.prod.raid.org.au/raids/10.82287/a8834a73",
    "registrationAgency": {
      "id": "https://ror.org/038sjwq14",
      "schemaUri": "https://ror.org/"
    },
    "schemaUri": "https://raid.org/",
    "version": 3
  },
  "metadata": {
    "created": 1780356836,
    "updated": 1780464748
  },
  "organisation": [
    {
      "id": "https://ror.org/0201hm243",
      "role": [
        {
          "id": "https://vocabulary.raid.org/organisation.role.schema/182",
          "schemaUri": "https://vocabulary.raid.org/organisation.role.schema/359",
          "startDate": "2026-03-12"
        }
      ],
      "schemaUri": "https://ror.org/",
      "rorDetails": {
        "rorId": "0201hm243",
        "name": "Phenomics Australia",
        "type": "Organization",
        "rorUrl": "https://ror.org/0201hm243"
      }
    }
  ],
  "relatedObject": [
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/g06z-nz80",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>Developing a humanized mouse model for Multiple Sclerosis</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/xr1v-n973",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>Studying enhancer function and the genetics of blood cell development from human induced pluripotent stem cells</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/5952-mk69",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>Screening for new treatments for glomerular disease with a new stem cell reporter line</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/y2gj-7v56",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>Testing precision medicines for Alzheimer's disease using advanced 3D human brain models</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/ev4r-k893",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>Creating an immunocompetent preclinical prostate cancer model to investigate targeting a tumour-driving transcription factor to stop disease</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/zvft-xp45",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>Developing rapid Pharmacodynamic AURKA Targeted Protein Degrader screening mice</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/mfzq-y642",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>Developing novel models of cardiomyopathy for therapeutic testing</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/atd5-kg38",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>Gene therapy to cure primary immunodeficiencies</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/s8dk-a066",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>Overcoming Silence in Neurodevelopmental Disorder Gene Diagnosis</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/jx68-k477",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>Engineering genetic mouse models of severe childhood epilepsy to test the efficacy of venom peptides as a therapeutic strategy</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/840j-5j19",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>Identifying patient-specific treatments that target plasticity in colorectal cancer via high throughput screening</i>. Phenomics Australia."
      }
    }
  ],
  "relatedRaid": [],
  "spatialCoverage": [],
  "subject": [],
  "title": [
    {
      "endDate": "2024-12-30",
      "startDate": "2024-09-01",
      "text": "Pipeline Accelerator - Voucher Scheme - 24-25 Round 1",
      "type": {
        "id": "https://vocabulary.raid.org/title.type.schema/5",
        "schemaUri": "https://vocabulary.raid.org/title.type.schema/376"
      }
    }
  ]
}

Page generated: